Results 131 to 140 of about 189,589 (267)

Emerging Trends in Patients Hospitalised With Cirrhosis—Aetiologies, Complications and Outcomes Compared to Other Chronic Health Conditions

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1108-1124, December 2025.
Rates of inpatient mortality and complication rates in cirrhosis remain high. With regard to inpatient outcomes, cirrhosis is falling behind other chronic health conditions. ABSTRACT Background The aetiologies, complications and overall burden of cirrhosis have undergone changes in recent years.
Julian Pohl, Nirbaanjot Walia, Lukas Hofmann, Lena Wolters, Martin Schulz, Matthias Reinhardt, Brigitta Globke, Frank Tacke, Thomas Berg, Cornelius Engelmann   +9 more
wiley   +1 more source

Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non‐Acute Decompensation

Alimentary Pharmacology &Therapeutics, Volume 62, Issue 11-12, Page 1202-1211, December 2025.
The novel classification of acute and non‐acute decompensation provides prognostic information, but the role of hospitalisation status should be reconsidered. ABSTRACT Background A more granular understanding of hepatic decompensation in cirrhosis has led to the classification of acute decompensation (AD) and non‐acute decompensation (NAD).
Lucie Simonis, Lorenz Balcar, Anna Schedlbauer, Marta Tonon, Nikolaj Torp, Valeria Santori, Katharina Stopfer, Jan Embacher, Christian Sebesta, Leonie Hafner, Benedikt Silvester Hofer, Nina Dominik, Georg Kramer, Paul Thöne, Michael Trauner, Aleksander Krag, Salvatore Piano, Mattias Mandorfer, Thomas Reiberger, Georg Semmler   +19 more
wiley   +1 more source

Acute partial Budd-Chiari syndrome and portal vein thrombosis in cytomegalovirus primary infection: a case report [PDF]

, 2006
Laurent Spahr, Andreas Cerny, Isabelle Morard, Laura Rubbia‐Brandt, Jacques Schrenzel   +4 more
openalex   +1 more source

Clinical Perspectives on Long‐Term Albumin Therapy in Decompensated Cirrhosis: A Nationwide Delphi Survey in Spain—The ALBA Study

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aims Albumin is well established for some acute indications in decompensated cirrhosis, but its long‐term use remains controversial. The ALBA study explored expert clinical perspectives, barriers, and current practices regarding long‐term albumin therapy in Spain.
Jose Ignacio Fortea, Diego Rincon Rodríguez, Agustín Albillos, Elsa Solá Vergés, Rafael Bañares   +4 more
wiley   +1 more source

Liver Transplantation in Patients With Portal Vein Thrombosis and Central Portacaval Shunts

, 1991
Abraham Shaked, Ronald W. Busuttil
openalex   +2 more sources

Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight‐Patient Case Series in the Pre‐siRNA Era

Pediatric Transplantation, Volume 29, Issue 8, December 2025.
ABSTRACT Background Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder that leads to systemic oxalosis and end‐stage renal disease (ESRD). Before the advent of siRNA therapy, liver transplantation, often combined with kidney transplantation, was the only definitive treatment.
Gal Finer, Alexandre N. Darani, Matthew G. Switalski, Sarah E. Ward, Hector Melin‐Aldana, Riccardo Superina   +5 more
wiley   +1 more source

Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians

CA: A Cancer Journal for Clinicians, Volume 75, Issue 6, Page 498-527, November/December 2025.
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris, Alessandro Martinino, Sarah Schiltz, Peter J. Allen, Andrew Barbas, Debra Sudan, Lindsay King, Carl Berg, Charles Kim, Mustafa Bashir, Manisha Palta, Michael A. Morse, Michael E. Lidsky   +12 more
wiley   +1 more source

Prevalence and Risk Factors for Portal Cavernoma in Adult Patients with Portal Vein Thrombosis [PDF]

Sergiu Marian Cazacu, Dragoș Ovidiu Alexandru, Daniela Dumitrescu, Alexandru Marian Vieru, Cristiana Marinela Urhuț, Larisa Săndulescu   +5 more
openalex   +1 more source

Acute Portal Vein Thrombosis, No Longer a Contraindication for Transjugular Intrahepatic Porto-Systemic Shunt (TIPS) Insertion [PDF]

, 2014
Suraj Mammen, Shyamkumar N. Keshava, Sajith Kattiparambil   +2 more
openalex   +1 more source

Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency. [PDF]

, 1988
Dominique Valla, Marie‐Hélène Denninger, J Delvigne, B Rueff, J P Benhamou   +4 more
openalex   +1 more source